the russian pharmaceutical company nova medica is the first to combine them in just one tablet.rtant for patients who regularly forget to take their medication. often what is important is not the creation of a new molecule, but the creation of a convenient release form. and many manufacturers, including us, are working. to improve the delivery method, to make therapy possible for the patient is more, we call this compliant, to make it easier for the patient to comply with the dosage regimen, by 2030 the share of russian full-cycle drugs on the domestic market should increase to almost 70%. such goals are stated in the government-approved strategy for the development of the pharmaceutical industry, it also provides for the elimination of administrative barriers , the accelerated introduction of new technological... solutions, but scientists and pharmaceutical companies go further, creating innovative drugs for serious diseases that no one else has in the world. world. sergei lukyanov first encountered ankylosing spondylitis when he was still a student; since then he has devoted h